Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

For Chronic Fatigue Syndrome, A 'Shifting Tide' At NIH

Monday 14 November 2016


From Science:



For chronic fatigue syndrome, a ‘shifting tide’ at NIH

By Meredith Wadman*
Science 11 Nov 2016:
Vol. 354, Issue 6313, pp. 691-692
DOI: 10.1126/science.354.6313.691
© 2016 American Association for the Advancement of Science. All rights Reserved.


It has been almost 30 years since researchers led by the U.S. Centers for Disease Control and Prevention coined the term chronic fatigue syndrome (CFS) to describe a mysterious malady characterized by profound fatigue that worsens with exertion and is not relieved by sleep. Sufferers, who prefer to call the illness myalgic encephalomyelitis, also cope with a basket of other persistent and disabling symptoms, from muscle pain to memory problems.

For years, patients and scientists alike have complained of being ignored by the nation's major medical research funder: In 2016, the $32.3 billion National Institutes of Health (NIH) directed about $7.6 million to research on the illness.

Now, in the wake of a public commitment to the disease by agency director Francis Collins, NIH is stepping up its game, anchoring oversight of the illness in its prominent neurological institute and planning for a doubling of its research investment in 2017.

Some of the additional money will fund several new extramural research centers. And last month, the agency began an intensive study of 40 patients at its on-campus research hospital.

However, a number of patients and scientists remain unconvinced that the agency has turned a corner, and NIH angered them last week by inviting a prominent CFS skeptic to give a 9 November talk on its Bethesda, Maryland, campus.

(* in Fort Lauderdale, Florida)


Full article…



blog comments powered by Disqus
Previous Previous Page